Nov 14, 2022 / 11:00AM GMT
Operator
Thank you. Good afternoon, everyone, and a very warm welcome to Ipca Labs Q2 FY '23 Fourth Earnings Call hosted by DAM Capital Advisors Private Limited. On the call representing today Ipca Lab management, we have Mr. A.K. Jain, Joint Managing Director; and Mr. Harish Kamath, Corporate Counsel and Company Secretary. I'll hand over the call to the management team to make the opening comments, and then we'll take it forward from there.
Harish P. Kamath - Ipca Laboratories Limited - Compliance Officer, Corporate Counsel & Company Secretary
Thanks, Nitin, and then Capital Advisors for organizing this call. Good afternoon to all participants, and thanks for taking out time and joining us for Q2 FY '23 earnings call. Today's end earnings call and discussions and answer given may include some forward-looking statements based on our current business expectations, that must be viewed in conjunction with the risk that pharmaceutical industry faces. Our actual future financial performance may differ from what is projected and perceived. You may take your own judgment on
Q2 2023 IPCA Laboratories Ltd Earnings Call Transcript
Nov 14, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers